UBS Group’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Sell |
|
|||||
|
2025
Q1 | $2.34M | Buy |
|
|||||
|
2024
Q4 | $1.97M | Buy |
|
|||||
|
2024
Q3 | $175K | Sell |
|
|||||
|
2024
Q2 | $384K | Sell |
|
|||||
|
2024
Q1 | $2.13M | Buy |
|
|||||
|
2023
Q4 | $555K | Buy |
|
|||||
|
2023
Q3 | $516K | Sell |
|
|||||
|
2023
Q2 | $925K | Sell |
|
|||||
|
2023
Q1 | $1.17M | Buy |
|
|||||
|
2022
Q4 | $520K | Buy |
|
|||||
|
2022
Q3 | $475K | Buy |
|
|||||
|
2022
Q2 | $403K | Buy |
|
|||||
|
2022
Q1 | $104K | Buy |
|
|||||
|
2021
Q4 | $178K | Buy |
|
|||||
|
2021
Q3 | $193K | Sell |
|
|||||
|
2021
Q2 | $8.35M | Buy |
|
|||||
|
2021
Q1 | $364K | Buy |
|
|||||
|
2020
Q4 | $288K | Buy |
|
|||||
|
2020
Q3 | $57K | Buy |
|